Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 96, Issue 2, Pages 249-259
Publisher
Springer Nature
Online
2015-12-14
DOI
10.1038/labinvest.2015.150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Abstract 2408: Identification of R-Spondin fusions in various types of human cancer
- (2015) Gabriela Martinez Cardona et al. CANCER RESEARCH
- Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
- (2014) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Analysis of wntless (WLS) expression in gastric, ovarian and breast cancers reveals a strong association with HER2 overexpression
- (2014) Jonathan Stewart et al. MODERN PATHOLOGY
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
- (2013) X. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer
- (2012) K. D. Proffitt et al. CANCER RESEARCH
- Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype
- (2012) Francesca Ricci et al. CELL CYCLE
- Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment
- (2011) Maria V. Barbolina et al. BIOCHEMICAL JOURNAL
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wnt signaling in stem and cancer stem cells
- (2010) Peter Wend et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
- (2009) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
- (2009) Noriyuki Katsumata et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now